These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 28560711)

  • 1. Recent advances in hypertrophic scar.
    Zhang J; Li Y; Bai X; Li Y; Shi J; Hu D
    Histol Histopathol; 2018 Jan; 33(1):27-39. PubMed ID: 28560711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological approaches for hypertrophic scars.
    Lingzhi Z; Meirong L; Xiaobing F
    Int Wound J; 2020 Apr; 17(2):405-418. PubMed ID: 31860941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow concentrate-induced mesenchymal stem cell conditioned medium facilitates wound healing and prevents hypertrophic scar formation in a rabbit ear model.
    Hu CH; Tseng YW; Chiou CY; Lan KC; Chou CH; Tai CS; Huang HD; Hu CW; Liao KH; Chuang SS; Yang JY; Lee OK
    Stem Cell Res Ther; 2019 Aug; 10(1):275. PubMed ID: 31462299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of fibrotic changes by the synergistic effects of cytokines, dimensionality and matrix: Towards the development of an in vitro human dermal hypertrophic scar model.
    Chawla S; Ghosh S
    Acta Biomater; 2018 Mar; 69():131-145. PubMed ID: 29330036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pirfenidone attenuates the profibrotic contractile phenotype of differentiated human dermal myofibroblasts.
    Wells AR; Leung KP
    Biochem Biophys Res Commun; 2020 Jan; 521(3):646-651. PubMed ID: 31679692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-β/Smad pathway.
    Bai X; He T; Liu J; Wang Y; Fan L; Tao K; Shi J; Tang C; Su L; Hu D
    Exp Dermatol; 2015 May; 24(5):355-60. PubMed ID: 25683490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A histological study on the effect of pressure therapy on the activities of myofibroblasts and keratinocytes in hypertrophic scar tissues after burn.
    Li-Tsang CW; Feng B; Huang L; Liu X; Shu B; Chan YT; Cheung KK
    Burns; 2015 Aug; 41(5):1008-16. PubMed ID: 25681960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
    Fang F; Huang RL; Zheng Y; Liu M; Huo R
    J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Keratinocytes on Myofibroblasts in Hypertrophic Scars.
    Lee JS; Kim JS; Lee JW; Choi KY; Yang JD; Cho BC; Oh EJ; Kim TJ; Ko UH; Shin JH; Jeon S; Lee YJ; Chung HY
    Aesthetic Plast Surg; 2019 Oct; 43(5):1371-1380. PubMed ID: 31346713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermis promotes dermal fibrosis: role in the pathogenesis of hypertrophic scars.
    Bellemare J; Roberge CJ; Bergeron D; Lopez-Vallé CA; Roy M; Moulin VJ
    J Pathol; 2005 May; 206(1):1-8. PubMed ID: 15772942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipose-derived mesenchymal stem cells suppress fibroblast proliferation of hypertrophic scar through CCL5 and CXCL12.
    Chen B; Zhu X; Zhang D; Zhu Z; Ye Q; Guo J
    Arch Dermatol Res; 2024 Aug; 316(8):527. PubMed ID: 39153095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanotransduction in skin wound healing and scar formation: Potential therapeutic targets for controlling hypertrophic scarring.
    Yin J; Zhang S; Yang C; Wang Y; Shi B; Zheng Q; Zeng N; Huang H
    Front Immunol; 2022; 13():1028410. PubMed ID: 36325354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of keratinocyte-fibroblast cross-talk in development of hypertrophic scar.
    Ghahary A; Ghaffari A
    Wound Repair Regen; 2007; 15 Suppl 1():S46-53. PubMed ID: 17727467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periostin induces fibroblast proliferation and myofibroblast persistence in hypertrophic scarring.
    Crawford J; Nygard K; Gan BS; O'Gorman DB
    Exp Dermatol; 2015 Feb; 24(2):120-6. PubMed ID: 25421393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated keratinocytes in the epidermis of hypertrophic scars.
    Machesney M; Tidman N; Waseem A; Kirby L; Leigh I
    Am J Pathol; 1998 May; 152(5):1133-41. PubMed ID: 9588880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and molecular pathology of HTS: basis for treatment.
    Armour A; Scott PG; Tredget EE
    Wound Repair Regen; 2007; 15 Suppl 1():S6-17. PubMed ID: 17727469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth factor pathways in hypertrophic scars: Molecular pathogenesis and therapeutic implications.
    Lian N; Li T
    Biomed Pharmacother; 2016 Dec; 84():42-50. PubMed ID: 27636511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural behavior of mononuclear phagocytes in HTS formation.
    Zhu Z; Ding J; Ma Z; Iwashina T; Tredget EE
    Wound Repair Regen; 2016; 24(1):14-25. PubMed ID: 26519112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential cellular and molecular causes of hypertrophic scar formation.
    van der Veer WM; Bloemen MC; Ulrich MM; Molema G; van Zuijlen PP; Middelkoop E; Niessen FB
    Burns; 2009 Feb; 35(1):15-29. PubMed ID: 18952381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human hypertrophic scar-like nude mouse model: characterization of the molecular and cellular biology of the scar process.
    Wang J; Ding J; Jiao H; Honardoust D; Momtazi M; Shankowsky HA; Tredget EE
    Wound Repair Regen; 2011; 19(2):274-85. PubMed ID: 21362096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.